TrialJournal of the American Heart Association2017

Clarithromycin Plus Intravenous Immunoglobulin Therapy Can Reduce the Relapse Rate of Kawasaki Disease: A Phase 2, Open-Label, Randomized Control Study.

Etsuro Nanishi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.